NMS·Healthcare·$767M·#149 / 520 in Healthcare
CBLL CeriBell, Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH58
QUALITY60
STABILITY56
VALUATION52
GOVERNANCE68
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+36.1%
58
> 50% strong
Gross Margin
Revenue retained after direct costs
87.9%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
12 months
40
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
14.3%
89
< 25% strong
Price / Sales
Market cap relative to trailing revenue
8.6x
52
< 3x strong
Rule of 40
Growth rate plus operating margin
-29
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.8%
69
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+5.5%
67
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CBLL WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CBLL's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.